TY - JOUR AU - Hay, M. AU - Thomas, D. W. AU - Craighead, J. L. AU - Economides, C. AU - Rosenthal, J. PY - 2014 DA - 2014// TI - Clinical development success rates for investigational drugs JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt.2786 DO - 10.1038/nbt.2786 ID - Hay2014 ER - TY - STD TI - World Preview 2018: Embracing the Patent Cliff. http://info.evaluatepharma.com/WP2018_ELS_LP.html. Accessed Sept 2015. UR - http://info.evaluatepharma.com/WP2018_ELS_LP.html ID - ref2 ER - TY - STD TI - Pharmaceutical Research and Manufactureres of America. Annual Report 2011. http://www.phrma.org/sites/default/files/159/phrma_2011_annual_report.pdf. Accessed Sept 2015. UR - http://www.phrma.org/sites/default/files/159/phrma_2011_annual_report.pdf ID - ref3 ER - TY - JOUR AU - Cohen, F. J. PY - 2005 DA - 2005// TI - Macro trends in pharmaceutical innovation JO - Nat Rev Drug Discov VL - 4 UR - https://doi.org/10.1038/nrd1610 DO - 10.1038/nrd1610 ID - Cohen2005 ER - TY - JOUR AU - Ribatti, D. AU - Vacca, A. AU - Dammacco, F. PY - 1999 DA - 1999// TI - The role of the vascular phase in solid tumor growth: a historical review JO - Neoplasia VL - 1 UR - https://doi.org/10.1038/sj.neo.7900038 DO - 10.1038/sj.neo.7900038 ID - Ribatti1999 ER - TY - JOUR AU - Ferrara, N. PY - 2010 DA - 2010// TI - Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy JO - Nat Med VL - 16 UR - https://doi.org/10.1038/nm1010-1107 DO - 10.1038/nm1010-1107 ID - Ferrara2010 ER - TY - JOUR AU - Ferrara, N. AU - Hillan, K. J. AU - Gerber, H. -. P. AU - Novotny, W. PY - 2004 DA - 2004// TI - Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1381 DO - 10.1038/nrd1381 ID - Ferrara2004 ER - TY - JOUR AU - Presta, L. G. AU - Chen, H. AU - O’Connor, S. J. AU - Chisholm, V. AU - Meng, Y. G. AU - Krummen, L. PY - 1997 DA - 1997// TI - Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders JO - Cancer Res VL - 57 ID - Presta1997 ER - TY - JOUR AU - Kim, K. J. AU - Li, B. AU - Winer, J. AU - Armanini, M. AU - Gillett, N. AU - Phillips, H. S. PY - 1993 DA - 1993// TI - Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo JO - Nature VL - 362 UR - https://doi.org/10.1038/362841a0 DO - 10.1038/362841a0 ID - Kim1993 ER - TY - STD TI - Avastin 25 mg/ml concentrate for solution for infusion. Bevacizumab. Last updated 22 October 2015. http://www.medicines.org.uk/emc/medicine/15748#INDICATIONS. Accessed Sept 2015. UR - http://www.medicines.org.uk/emc/medicine/15748#INDICATIONS ID - ref10 ER - TY - JOUR AU - Michelson, I. PY - 1948 DA - 1948// TI - The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders JO - Trans Ophthalmol Soc UK VL - 68 ID - Michelson1948 ER - TY - JOUR AU - Lopez, P. F. AU - Sippy, B. D. AU - Michael Lambert, H. AU - Thach, A. B. AU - Hinton, D. R. PY - 1996 DA - 1996// TI - Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes JO - Investig Ophthalmol Vis Sci VL - 37 ID - Lopez1996 ER - TY - JOUR AU - Kvanta, A. AU - Algvere, P. V. AU - Berglin, L. AU - Seregard, S. PY - 1996 DA - 1996// TI - Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor JO - Investig Ophthalmol Vis Sci VL - 37 ID - Kvanta1996 ER - TY - JOUR AU - Aiello, L. P. AU - Pierce, E. A. AU - Foley, E. D. AU - Takagi, H. AU - Chen, H. AU - Riddle, L. PY - 1995 DA - 1995// TI - Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins JO - Proc Natl Acad Sci U S A VL - 92 UR - https://doi.org/10.1073/pnas.92.23.10457 DO - 10.1073/pnas.92.23.10457 ID - Aiello1995 ER - TY - JOUR AU - Adamis, A. P. AU - Shima, D. T. AU - Tolentino, M. J. AU - Gragoudas, E. S. AU - Ferrara, N. AU - Folkman, J. PY - 1996 DA - 1996// TI - Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate JO - Arch Ophthalmol VL - 114 UR - https://doi.org/10.1001/archopht.1996.01100130062010 DO - 10.1001/archopht.1996.01100130062010 ID - Adamis1996 ER - TY - JOUR AU - Campochiaro, P. A. AU - Hackett, S. F. PY - 2003 DA - 2003// TI - Ocular neovascularization: a valuable model system JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206773 DO - 10.1038/sj.onc.1206773 ID - Campochiaro2003 ER - TY - JOUR AU - Gragoudas, E. S. AU - Adamis, A. P. AU - Cunningham, E. T. AU - Feinsod, M. AU - Guyer, D. R. PY - 2004 DA - 2004// TI - Pegaptanib for neovascular age-related macular degeneration JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa042760 DO - 10.1056/NEJMoa042760 ID - Gragoudas2004 ER - TY - JOUR AU - Mordenti, J. AU - Cuthbertson, R. A. AU - Ferrara, N. AU - Thomsen, K. AU - Berleau, L. AU - Licko, V. PY - 1999 DA - 1999// TI - Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration JO - Toxicol Pathol VL - 27 UR - https://doi.org/10.1177/019262339902700507 DO - 10.1177/019262339902700507 ID - Mordenti1999 ER - TY - JOUR AU - Krzystolik, M. G. AU - Afshari, M. A. AU - Adamis, A. P. AU - Gaudreault, J. AU - Gragoudas, E. S. AU - Michaud, N. A. PY - 2002 DA - 2002// TI - Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment JO - Arch Ophthalmol VL - 120 UR - https://doi.org/10.1001/archopht.120.3.338 DO - 10.1001/archopht.120.3.338 ID - Krzystolik2002 ER - TY - JOUR AU - Heier, J. S. AU - Antoszyk, A. N. AU - Pavan, P. R. AU - Leff AU - Steven, R. AU - Rosenfeld, P. J. PY - 2006 DA - 2006// TI - Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study JO - Ophthalmology VL - 113 UR - https://doi.org/10.1016/j.ophtha.2005.10.052 DO - 10.1016/j.ophtha.2005.10.052 ID - Heier2006 ER - TY - JOUR AU - Rosenfeld, P. J. AU - Brown, D. M. AU - Heier, J. S. AU - Boyer AU - David, S. AU - Kaiser, P. K. PY - 2006 DA - 2006// TI - Ranibizumab for neovascular age-related macular degeneration JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa054481 DO - 10.1056/NEJMoa054481 ID - Rosenfeld2006 ER - TY - JOUR AU - Jager, R. D. AU - Mieler, W. F. AU - Miller, J. W. PY - 2008 DA - 2008// TI - Age-related macular degeneration JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMra0801537 DO - 10.1056/NEJMra0801537 ID - Jager2008 ER - TY - STD TI - Lucentis 10 mg/ml solution for injection. Ranibizumab. Last updated 24 September 2015. http://www.medicines.org.uk/emc/medicine/19409. Accessed Sept 2015 UR - http://www.medicines.org.uk/emc/medicine/19409 ID - ref23 ER - TY - STD TI - Forbes analysis 2013. http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/. Accessed Sept 2015. UR - http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/ ID - ref24 ER - TY - JOUR AU - Paul, S. M. AU - Mytelka, D. S. AU - Dunwiddie, C. T. AU - Persinger, C. C. AU - Munos, B. H. AU - Lindborg, S. R. PY - 2010 DA - 2010// TI - How to improve R&D productivity: the pharmaceutical industry’s grand challenge JO - Nat Rev Drug Discov VL - 9 ID - Paul2010 ER - TY - JOUR AU - Booth, B. AU - Zemmel, R. PY - 2004 DA - 2004// TI - Prospects for productivity JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1384 DO - 10.1038/nrd1384 ID - Booth2004 ER - TY - JOUR AU - Khanna, I. PY - 2012 DA - 2012// TI - Drug discovery in pharmaceutical industry: Productivity challenges and trends JO - Drug Discov Today VL - 17 UR - https://doi.org/10.1016/j.drudis.2012.05.007 DO - 10.1016/j.drudis.2012.05.007 ID - Khanna2012 ER - TY - JOUR AU - Sams-Dodd, F. PY - 2013 DA - 2013// TI - Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift JO - Drug Discov Today VL - 18 UR - https://doi.org/10.1016/j.drudis.2012.10.010 DO - 10.1016/j.drudis.2012.10.010 ID - Sams-Dodd2013 ER - TY - JOUR AU - Swinney, D. C. AU - Anthony, J. PY - 2011 DA - 2011// TI - How were new medicines discovered? JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3480 DO - 10.1038/nrd3480 ID - Swinney2011 ER - TY - JOUR AU - Pammolli, F. AU - Magazzini, L. AU - Riccaboni, M. PY - 2011 DA - 2011// TI - The productivity crisis in pharmaceutical R&D JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3405 DO - 10.1038/nrd3405 ID - Pammolli2011 ER - TY - JOUR AU - Zhang, K. AU - Zhang, L. AU - Weinreb, R. N. PY - 2012 DA - 2012// TI - Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma JO - Nat Rev Drug Discov VL - 11 UR - https://doi.org/10.1038/nrd3745 DO - 10.1038/nrd3745 ID - Zhang2012 ER - TY - JOUR AU - Gaudana, R. AU - Ananthula, H. K. AU - Parenky, A. AU - Mitra, A. K. PY - 2010 DA - 2010// TI - Ocular drug delivery JO - AAPS J VL - 12 UR - https://doi.org/10.1208/s12248-010-9183-3 DO - 10.1208/s12248-010-9183-3 ID - Gaudana2010 ER - TY - STD TI - Patel A, Cholkar K, Agrahari V, Mitra A. Ocular drug delivery systems: An overview. 2013. http://www.wjgnet.com/2220-3192/full/v2/i2/47.htm. Accessed November 10, 2014 UR - http://www.wjgnet.com/2220-3192/full/v2/i2/47.htm ID - ref33 ER - TY - JOUR AU - Cholkar, K. AU - Patel, S. P. AU - Vadlapudi, A. D. AU - Mitra, A. K. PY - 2013 DA - 2013// TI - Novel strategies for anterior segment ocular drug delivery JO - J Ocul Pharmacol Ther VL - 29 UR - https://doi.org/10.1089/jop.2012.0200 DO - 10.1089/jop.2012.0200 ID - Cholkar2013 ER - TY - JOUR AU - Strungaru, M. H. AU - Peck, J. AU - Compeau, E. C. AU - Trope, G. E. AU - Buys, Y. M. PY - 2014 DA - 2014// TI - Mirror-hat device as a drop delivery aid: a pilot study JO - Can J Ophthalmol VL - 49 UR - https://doi.org/10.1016/j.jcjo.2014.04.012 DO - 10.1016/j.jcjo.2014.04.012 ID - Strungaru2014 ER - TY - JOUR AU - An, J. A. AU - Kasner, O. AU - Samek, D. A. AU - Lévesque, V. PY - 2014 DA - 2014// TI - Evaluation of eyedrop administration by inexperienced patients after cataract surgery JO - J Cataract Refract Surg VL - 40 UR - https://doi.org/10.1016/j.jcrs.2014.02.037 DO - 10.1016/j.jcrs.2014.02.037 ID - An2014 ER - TY - JOUR AU - Sanabria, M. R. AU - Montero, J. A. AU - Losada, M. V. AU - Fernández-Muñoz, M. AU - Galindo, A. AU - Fernández, I. PY - 2013 DA - 2013// TI - Ocular pain after intravitreal injection JO - Curr Eye Res VL - 38 UR - https://doi.org/10.3109/02713683.2012.758290 DO - 10.3109/02713683.2012.758290 ID - Sanabria2013 ER - TY - JOUR AU - Denniston, A. K. AU - Dick, A. D. PY - 2013 DA - 2013// TI - Systemic therapies for inflammatory eye disease: past, present and future JO - BMC Ophthalmol VL - 13 UR - https://doi.org/10.1186/1471-2415-13-18 DO - 10.1186/1471-2415-13-18 ID - Denniston2013 ER - TY - JOUR AU - Hornbeak, D. M. AU - Payal, A. AU - Pistilli, M. AU - Biswas, J. AU - Ganesh, S. K. AU - Gupta, V. PY - 2014 DA - 2014// TI - Interobserver agreement in clinical grading of vitreous haze using alternative grading scales JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2014.02.018 DO - 10.1016/j.ophtha.2014.02.018 ID - Hornbeak2014 ER - TY - JOUR AU - Querques, G. AU - Rosenfeld, P. J. AU - Cavallero, E. AU - Borrelli, E. AU - Corvi, F. AU - Querques, L. PY - 2014 DA - 2014// TI - Treatment of Dry Age-Related Macular Degeneration JO - Ophthalmic Res VL - 52 UR - https://doi.org/10.1159/000363187 DO - 10.1159/000363187 ID - Querques2014 ER - TY - STD TI - BCC Research market research report. www.bccresearch.com/market-research/pharmaceuticals/ophthalmic-therapeutic-drugs-phm031c.html. Accessed Sept 2015 UR - http://www.bccresearch.com/market-research/pharmaceuticals/ophthalmic-therapeutic-drugs-phm031c.html ID - ref41 ER - TY - STD TI - Reuters 2015 report. www.reuters.com/article/2015/02/10/us-health-glaucoma-idUSKBN0LE0DG20150210. Accessed Sept 2015 UR - http://www.reuters.com/article/2015/02/10/us-health-glaucoma-idUSKBN0LE0DG20150210 ID - ref42 ER - TY - JOUR AU - Weinreb, R. N. AU - Ong, T. AU - Scassellati Sforzolini, B. AU - Vittitow, J. L. AU - Singh, K. AU - Kaufman, P. L. PY - 2015 DA - 2015// TI - A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005 % in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study JO - Br J Ophthalmol VL - 99 UR - https://doi.org/10.1136/bjophthalmol-2014-305908 DO - 10.1136/bjophthalmol-2014-305908 ID - Weinreb2015 ER - TY - JOUR AU - Moreno-Montañés, J. AU - Sádaba, B. AU - Ruz, V. AU - Gómez-Guiu, A. AU - Zarranz, J. AU - González, M. V. PY - 2014 DA - 2014// TI - Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2013.217 DO - 10.1038/mt.2013.217 ID - Moreno-Montañés2014 ER - TY - JOUR AU - Goldberg, D. F. AU - Williams, R. PY - 2012 DA - 2012// TI - A Phase 2 study evaluating safety and efficacy of the latanoprost punctal plug delivery system (L-PPDS) in subjects with ocular hypertension (OH) or open-angle glaucoma (OAG) JO - Invest Ophthalmol Vis Sci VL - 53 ID - Goldberg2012 ER - TY - JOUR AU - Amadi-Obi, A. AU - Yu, C. -. R. AU - Liu, X. AU - Mahdi AU - Rashid, M. AU - Clarke, G. L. PY - 2007 DA - 2007// TI - TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1585 DO - 10.1038/nm1585 ID - Amadi-Obi2007 ER - TY - JOUR AU - Dick, A. D. AU - Tugal-Tutkun, I. AU - Foster, S. AU - Zierhut, M. AU - Melissa, L. S. H. AU - Bezlyak, V. PY - 2013 DA - 2013// TI - Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials JO - Ophthalmology VL - 120 UR - https://doi.org/10.1016/j.ophtha.2012.09.040 DO - 10.1016/j.ophtha.2012.09.040 ID - Dick2013 ER - TY - JOUR AU - Letko, E. AU - Yeh, S. AU - Foster, C. S. AU - Pleyer, U. AU - Brigell, M. AU - Grosskreutz, C. L. PY - 2015 DA - 2015// TI - Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2014.12.033 DO - 10.1016/j.ophtha.2014.12.033 ID - Letko2015 ER - TY - JOUR AU - Curnow, S. J. AU - Scheel-Toellner, D. AU - Jenkinson, W. AU - Raza, K. AU - Durrani, O. M. AU - Faint, J. M. PY - 2004 DA - 2004// TI - Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.8.5290 DO - 10.4049/jimmunol.173.8.5290 ID - Curnow2004 ER - TY - JOUR AU - Romano, M. AU - Sironi, M. AU - Toniatti, C. AU - Polentarutti, N. AU - Fruscella, P. AU - Ghezzi, P. PY - 1997 DA - 1997// TI - Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment JO - Immunity VL - 6 UR - https://doi.org/10.1016/S1074-7613(00)80334-9 DO - 10.1016/S1074-7613(00)80334-9 ID - Romano1997 ER - TY - JOUR AU - Mesquida, M. AU - Leszczynska, A. AU - Llorenç, V. AU - Adán, A. PY - 2014 DA - 2014// TI - Interleukin-6 blockade in ocular inflammatory diseases JO - Clin Exp Immunol VL - 176 UR - https://doi.org/10.1111/cei.12295 DO - 10.1111/cei.12295 ID - Mesquida2014 ER - TY - JOUR AU - Venkiteshwaran, A. PY - 2009 DA - 2009// TI - Tocilizumab JO - MAbs VL - 1 UR - https://doi.org/10.4161/mabs.1.5.9497 DO - 10.4161/mabs.1.5.9497 ID - Venkiteshwaran2009 ER - TY - JOUR AU - Tappeiner, C. AU - Heinz, C. AU - Ganser, G. AU - Heiligenhaus, A. PY - 2012 DA - 2012// TI - Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? JO - J Rheumatol VL - 39 UR - https://doi.org/10.3899/jrheum.120010 DO - 10.3899/jrheum.120010 ID - Tappeiner2012 ER - TY - JOUR AU - Hirano, T. AU - Ohguro, N. AU - Hohki, S. AU - Hagihara, K. AU - Shima, Y. AU - Narazaki, M. PY - 2012 DA - 2012// TI - A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab JO - Mod Rheumatol VL - 22 UR - https://doi.org/10.3109/s10165-011-0497-5 DO - 10.3109/s10165-011-0497-5 ID - Hirano2012 ER - TY - JOUR AU - Oshitari, T. AU - Kajita, F. AU - Tobe, A. AU - Itami, M. AU - Yotsukura, J. AU - Baba, T. PY - 2012 DA - 2012// TI - Refractory uveitis in patient with castleman disease successfully treated with tocilizumab JO - Case Rep Ophthalmol Med VL - 2012 ID - Oshitari2012 ER - TY - JOUR AU - Tsang, A. C. AU - Roth, J. AU - Gottlieb, C. PY - 2014 DA - 2014// TI - Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient JO - Ocul Immunol Inflamm VL - 22 UR - https://doi.org/10.3109/09273948.2013.866254 DO - 10.3109/09273948.2013.866254 ID - Tsang2014 ER - TY - JOUR AU - Adán, A. AU - Mesquida, M. AU - Llorenç, V. AU - Espinosa, G. AU - Molins, B. AU - Hernández, M. V. PY - 2013 DA - 2013// TI - Tocilizumab treatment for refractory uveitis-related cystoid macular edema JO - Graefes Arch Clin Exp Ophthalmol VL - 251 UR - https://doi.org/10.1007/s00417-013-2436-y DO - 10.1007/s00417-013-2436-y ID - Adán2013 ER - TY - JOUR AU - Adán, A. AU - Llorenç, V. AU - Mesquida, M. AU - Pelegrín, L. PY - 2013 DA - 2013// TI - Tocilizumab treatment for recalcitrant uveitic macular edema JO - Graefes Arch Clin Exp Ophthalmol VL - 251 UR - https://doi.org/10.1007/s00417-012-2243-x DO - 10.1007/s00417-012-2243-x ID - Adán2013 ER - TY - JOUR AU - Muselier, A. AU - Bielefeld, P. AU - Bidot, S. AU - Vinit, J. AU - Besancenot, J. -. F. AU - Bron, A. PY - 2011 DA - 2011// TI - Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis JO - Ocul Immunol Inflamm VL - 19 UR - https://doi.org/10.3109/09273948.2011.606593 DO - 10.3109/09273948.2011.606593 ID - Muselier2011 ER - TY - JOUR AU - Smith, T. J. AU - Tsai, C. C. AU - Shih, M. -. J. AU - Tsui, S. AU - Chen, B. AU - Han, R. PY - 2008 DA - 2008// TI - Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy JO - Thyroid VL - 18 UR - https://doi.org/10.1089/thy.2007.0404 DO - 10.1089/thy.2007.0404 ID - Smith2008 ER - TY - JOUR AU - Douglas, R. S. AU - Gianoukakis, A. G. AU - Kamat, S. AU - Smith, T. J. PY - 2007 DA - 2007// TI - Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves’ disease may carry functional consequences for disease pathogenesis JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.5.3281 DO - 10.4049/jimmunol.178.5.3281 ID - Douglas2007 ER - TY - JOUR AU - Douglas, R. S. AU - Naik, V. AU - Hwang, C. J. AU - Afifiyan, N. F. AU - Gianoukakis, A. G. AU - Sand, D. PY - 2008 DA - 2008// TI - B cells from patients with Graves’ disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.8.5768 DO - 10.4049/jimmunol.181.8.5768 ID - Douglas2008 ER - TY - JOUR AU - Gianoukakis, A. G. AU - Douglas, R. S. AU - King, C. S. AU - Cruikshank, W. W. AU - Smith, T. J. PY - 2006 DA - 2006// TI - Immunoglobulin G from patients with Graves’ disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease JO - Endocrinology VL - 147 UR - https://doi.org/10.1210/en.2005-1375 DO - 10.1210/en.2005-1375 ID - Gianoukakis2006 ER - TY - JOUR AU - Smith, T. J. AU - Hoa, N. PY - 2004 DA - 2004// TI - Immunoglobulins from patients with Graves’ disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2004-0716 DO - 10.1210/jc.2004-0716 ID - Smith2004 ER - TY - JOUR AU - Ezra, D. G. AU - Krell, J. AU - Rose, G. E. AU - Bailly, M. AU - Stebbing, J. AU - Castellano, L. PY - 2012 DA - 2012// TI - Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy JO - J Clin Pathol VL - 65 UR - https://doi.org/10.1136/jclinpath-2012-200719 DO - 10.1136/jclinpath-2012-200719 ID - Ezra2012 ER - TY - JOUR AU - Salvi, M. PY - 2014 DA - 2014// TI - Immunotherapy for Graves’ ophthalmopathy JO - Curr Opin Endocrinol Diabetes Obes VL - 21 UR - https://doi.org/10.1097/MED.0000000000000097 DO - 10.1097/MED.0000000000000097 ID - Salvi2014 ER - TY - JOUR AU - Singh, M. AU - Murriel, C. L. AU - Johnson, L. PY - 2012 DA - 2012// TI - Genetically engineered mouse models: Closing the gap between preclinical data and trial outcomes JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-2786 DO - 10.1158/0008-5472.CAN-11-2786 ID - Singh2012 ER - TY - JOUR AU - Bennani, Y. L. PY - 2011 DA - 2011// TI - Drug discovery in the next decade: Innovation needed ASAP JO - Drug Discov Today VL - 16 UR - https://doi.org/10.1016/j.drudis.2011.06.004 DO - 10.1016/j.drudis.2011.06.004 ID - Bennani2011 ER - TY - CHAP AU - McNally, S. AU - O’Brien, C. J. PY - 2014 DA - 2014// TI - Drug discovery in glaucoma and the role of animal models BT - Drug Discovery Today: Disease Models ID - McNally2014 ER - TY - JOUR AU - Zeiss, C. J. PY - 2013 DA - 2013// TI - Translational models of ocular disease JO - Vet Ophthalmol VL - 16 UR - https://doi.org/10.1111/vop.12065 DO - 10.1111/vop.12065 ID - Zeiss2013 ER - TY - JOUR AU - Bouhenni, R. A. AU - Dunmire, J. AU - Sewell, A. AU - Edward, D. P. PY - 2012 DA - 2012// TI - Animal models of glaucoma JO - J Biomed Biotechnol VL - 2012 UR - https://doi.org/10.1155/2012/692609 DO - 10.1155/2012/692609 ID - Bouhenni2012 ER - TY - JOUR AU - Zeiss, C. J. PY - 2010 DA - 2010// TI - Animals as models of age-related macular degeneration: an imperfect measure of the truth JO - Vet Pathol VL - 47 UR - https://doi.org/10.1177/0300985809359598 DO - 10.1177/0300985809359598 ID - Zeiss2010 ER - TY - JOUR AU - Caspi, R. R. PY - 2014 DA - 2014// TI - Understanding autoimmunity in the eye: from animal models to novel therapies JO - Discov Med VL - 17 ID - Caspi2014 ER - TY - JOUR AU - Prabhakar, B. S. AU - Bahn, R. S. AU - Smith, T. J. PY - 2003 DA - 2003// TI - Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy JO - Endocr Rev VL - 24 UR - https://doi.org/10.1210/er.2002-0020 DO - 10.1210/er.2002-0020 ID - Prabhakar2003 ER - TY - JOUR AU - Baker, G. AU - Mazziotti, G. AU - Ruhland, C. AU - Ludgate, M. PY - 2005 DA - 2005// TI - Reevaluating thyrotropin receptor-induced mouse models of graves’ disease and ophthalmopathy JO - Endocrinology VL - 146 UR - https://doi.org/10.1210/en.2004-1015 DO - 10.1210/en.2004-1015 ID - Baker2005 ER - TY - JOUR AU - Many, M. C. AU - Costagliola, S. AU - Detrait, M. AU - Denef, F. AU - Vassart, G. AU - Ludgate, M. C. PY - 1999 DA - 1999// TI - Development of an animal model of autoimmune thyroid eye disease JO - J Immunol VL - 162 ID - Many1999 ER - TY - JOUR AU - Costagliola, S. AU - Many, M. C. AU - Stalmans-Falys, M. AU - Tonacchera, M. AU - Vassart, G. AU - Ludgate, M. PY - 1994 DA - 1994// TI - Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model JO - Endocrinology VL - 135 UR - https://doi.org/10.1210/endo.135.5.7956939 DO - 10.1210/endo.135.5.7956939 ID - Costagliola1994 ER - TY - JOUR AU - Costagliola, S. AU - Alcalde, L. AU - Tonacchera, M. AU - Ruf, J. AU - Vassart, G. AU - Ludgate, M. PY - 1994 DA - 1994// TI - Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R JO - Biochem Biophys Res Commun VL - 199 UR - https://doi.org/10.1006/bbrc.1994.1332 DO - 10.1006/bbrc.1994.1332 ID - Costagliola1994 ER - TY - JOUR AU - Costagliola, S. AU - Many, M. C. AU - Stalmans-Falys, M. AU - Vassart, G. AU - Ludgate, M. PY - 1996 DA - 1996// TI - Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice JO - Endocrinology VL - 137 UR - https://doi.org/10.1210/endo.137.11.8895327 DO - 10.1210/endo.137.11.8895327 ID - Costagliola1996 ER - TY - JOUR AU - Moshkelgosha, S. AU - So, P. -. W. AU - Deasy, N. AU - Diaz-Cano, S. AU - Banga, J. P. PY - 2013 DA - 2013// TI - Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves’ orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation JO - Endocrinology VL - 154 UR - https://doi.org/10.1210/en.2013-1576 DO - 10.1210/en.2013-1576 ID - Moshkelgosha2013 ER - TY - JOUR AU - Cook, N. AU - Jodrell, D. I. AU - Tuveson, D. A. PY - 2012 DA - 2012// TI - Predictive in vivo animal models and translation to clinical trials JO - Drug Discov Today VL - 17 UR - https://doi.org/10.1016/j.drudis.2012.02.003 DO - 10.1016/j.drudis.2012.02.003 ID - Cook2012 ER - TY - JOUR AU - Das Thakur, M. AU - Pryer, N. K. AU - Singh, M. PY - 2014 DA - 2014// TI - Mouse tumour models to guide drug development and identify resistance mechanisms JO - J Pathol VL - 232 UR - https://doi.org/10.1002/path.4285 DO - 10.1002/path.4285 ID - Das Thakur2014 ER - TY - JOUR AU - Urtti, A. PY - 2006 DA - 2006// TI - Challenges and obstacles of ocular pharmacokinetics and drug delivery JO - Adv Drug Deliv Rev VL - 58 UR - https://doi.org/10.1016/j.addr.2006.07.027 DO - 10.1016/j.addr.2006.07.027 ID - Urtti2006 ER - TY - JOUR AU - Thrimawithana, T. R. AU - Young, S. AU - Bunt, C. R. AU - Green, C. R. AU - Puglisi, G. AU - Alany, R. G. PY - 2011 DA - 2011// TI - Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities JO - Drug Deliv Lett VL - 1 ID - Thrimawithana2011 ER - TY - JOUR AU - Reardon, G. AU - Kotak, S. AU - Schwartz, G. F. PY - 2011 DA - 2011// TI - Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review JO - Patient Prefer Adherence VL - 5 UR - https://doi.org/10.2147/PPA.S23780 DO - 10.2147/PPA.S23780 ID - Reardon2011 ER - TY - JOUR AU - Ye, T. AU - Yuan, K. AU - Zhang, W. AU - Song, S. AU - Chen, F. AU - Yang, X. PY - 2013 DA - 2013// TI - Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery JO - Asian J Pharm Sci VL - 8 UR - https://doi.org/10.1016/j.ajps.2013.09.002 DO - 10.1016/j.ajps.2013.09.002 ID - Ye2013 ER - TY - JOUR AU - Eljarrat-Binstock, E. AU - Pe’er, J. AU - Domb, A. J. PY - 2010 DA - 2010// TI - New techniques for drug delivery to the posterior eye segment JO - Pharm Res VL - 27 UR - https://doi.org/10.1007/s11095-009-0042-9 DO - 10.1007/s11095-009-0042-9 ID - Eljarrat-Binstock2010 ER - TY - JOUR AU - Peyman, G. A. AU - Lad, E. M. AU - Moshfeghi, D. M. PY - 2009 DA - 2009// TI - Intravitreal injection of therapeutic agents JO - Retina VL - 29 UR - https://doi.org/10.1097/IAE.0b013e3181a94f01 DO - 10.1097/IAE.0b013e3181a94f01 ID - Peyman2009 ER - TY - STD TI - On Demand Therapeutics. www.ondemandtx.com. Accessed Sept 2015 UR - http://www.ondemandtx.com ID - ref89 ER - TY - JOUR AU - Zhang, K. AU - Hopkins, J. J. AU - Heier, J. S. AU - Birch, D. G. AU - Halperin, L. S. AU - Albini, T. A. PY - 2011 DA - 2011// TI - Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1018987108 DO - 10.1073/pnas.1018987108 ID - Zhang2011 ER - TY - STD TI - Neurotech. www.neurotechusa.com. Accessed Sept 2015 UR - http://www.neurotechusa.com ID - ref91 ER - TY - JOUR AU - Weiner, A. L. AU - Gilger, B. C. PY - 2010 DA - 2010// TI - Advancements in ocular drug delivery JO - Vet Ophthalmol VL - 13 UR - https://doi.org/10.1111/j.1463-5224.2010.00835.x DO - 10.1111/j.1463-5224.2010.00835.x ID - Weiner2010 ER - TY - JOUR AU - Bengani, L. C. AU - Hsu, K. -. H. AU - Gause, S. AU - Chauhan, A. PY - 2013 DA - 2013// TI - Contact lenses as a platform for ocular drug delivery JO - Expert Opin Drug Deliv VL - 10 UR - https://doi.org/10.1517/17425247.2013.821462 DO - 10.1517/17425247.2013.821462 ID - Bengani2013 ER - TY - STD TI - Eye gate pharma. www.eyegatepharma.com. Accessed Sept 2015. UR - http://www.eyegatepharma.com ID - ref94 ER - TY - JOUR AU - Halhal, M. AU - Renard, G. AU - Courtois, Y. AU - BenEzra, D. AU - Behar-Cohen, F. PY - 2004 DA - 2004// TI - Iontophoresis: from the lab to the bed side JO - Exp Eye Res VL - 78 UR - https://doi.org/10.1016/j.exer.2003.10.017 DO - 10.1016/j.exer.2003.10.017 ID - Halhal2004 ER - TY - JOUR AU - Arrowsmith, J. PY - 2011 DA - 2011// TI - Trial watch: Phase II failures: 2008–2010 JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3439 DO - 10.1038/nrd3439 ID - Arrowsmith2011 ER - TY - JOUR AU - Deyati, A. AU - Younesi, E. AU - Hofmann-Apitius, M. AU - Novac, N. PY - 2013 DA - 2013// TI - Challenges and opportunities for oncology biomarker discovery JO - Drug Discov Today VL - 18 UR - https://doi.org/10.1016/j.drudis.2012.12.011 DO - 10.1016/j.drudis.2012.12.011 ID - Deyati2013 ER - TY - JOUR AU - Paez, J. G. AU - Jänne, P. A. AU - Lee, J. C. AU - Tracy, S. AU - Greulich, H. AU - Gabriel, S. PY - 2004 DA - 2004// TI - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy JO - Science VL - 304 UR - https://doi.org/10.1126/science.1099314 DO - 10.1126/science.1099314 ID - Paez2004 ER - TY - JOUR AU - Roberts, P. J. AU - Stinchcombe, T. E. AU - Der, C. J. AU - Socinski, M. A. PY - 2010 DA - 2010// TI - Personalized medicine in non-small-cell lung cancer: Is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.4365 DO - 10.1200/JCO.2009.27.4365 ID - Roberts2010 ER - TY - JOUR AU - Kim, G. AU - McKee, A. E. AU - Ning, Y. -. M. AU - Hazarika, M. AU - Theoret, M. AU - Johnson, J. R. PY - 2014 DA - 2014// TI - FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0776 DO - 10.1158/1078-0432.CCR-14-0776 ID - Kim2014 ER - TY - JOUR AU - Chapman, P. B. AU - Hauschild, A. AU - Robert, C. AU - Haanen, J. B. AU - Ascierto, P. AU - Larkin, J. PY - 2011 DA - 2011// TI - Improved survival with vemurafenib in melanoma with BRAF V600E mutation JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1103782 DO - 10.1056/NEJMoa1103782 ID - Chapman2011 ER - TY - JOUR AU - Walker, I. AU - Newell, H. PY - 2009 DA - 2009// TI - Do molecularly targeted agents in oncology have reduced attrition rates? JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2758 DO - 10.1038/nrd2758 ID - Walker2009 ER - TY - JOUR AU - Tian, B. AU - Gabelt, B. T. AU - Crosson, C. E. AU - Kaufman, P. L. PY - 1997 DA - 1997// TI - Effects of Adenosine Agonists on Intraocular Pressure and Aqueous Humor Dynamics in Cynomolgus Monkeys JO - Exp Eye Res VL - 64 UR - https://doi.org/10.1006/exer.1997.0296 DO - 10.1006/exer.1997.0296 ID - Tian1997 ER - TY - JOUR AU - Bacharach, J. AU - Dubiner, H. B. AU - Levy, B. AU - Kopczynski, C. C. AU - Novack, G. D. PY - 2015 DA - 2015// TI - Double-masked, randomized, dose–response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2014.08.022 DO - 10.1016/j.ophtha.2014.08.022 ID - Bacharach2015 ER - TY - STD TI - Lewis RA, Levy B, Ramirez N, C Kopczynski C, Usner DW, Novack GD. Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension. Br J Ophthalmol. 2015, [Epub ahead of print] ID - ref105 ER -